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WC previously proposed that intracellular cyclic AMP accumulation induces u putative. rapidly turning over protein inhibitory to rurther hormone 
activation ol’adenylatc cyclase. In the prcscnt study , 2-aminopurina. which has been reported to sclcctively block c+s gm cxprcssion, was used 
to test the hypothesis that ~4’0s protein might be involved in the dcsensitizntion process. Indeed. a reduction in hetcrologous desensitization to 
catccholumines was observed in 2-aminopurinc-trcatcd CG-28 rat glioma cells, However. we found 2-aminopurino to inhibit, in a concentration- 
dependent manner. 10~1 cellular RNA and protein synthesis in CB-2B. FleLa. Swiss 3T3 and BALB/c cells. mRNA synthesis wus also markedly 
reduced in 2.aminopurinc-treated cells. Thcsc uncxpccted findings, while supporting our hypothesis of a protein synthesis-sensitive step in the 
dcvclopmcnt of refractoriness. r&x concern about the specificity of action of 7 --aminopurinc to inhibit c-/i,s induction and thus any cellular process, 
including desensitization, which might be rcgulatcd by c-/bs gene expression. 
c+s; Ccl1 biosynthesis; Rcfructoriness 
I. INTRODUCTION 
Our laboratory has previously shown in several cell 
systems that inhibitors of RNA and protein synthesis, 
such as actinomycin D, cycloheximide and diphtheria 
toxin, reduce or reverse cyclic AMP (CAMP)-mediated 
heterologous catecholamine desensitization [l-3]. 
Therefore. our working hypothesis is that stimulation 
of intracellular CAMP accumulation induces a rapidly 
turning over protein which inhibits subsequent hor- 
monal responses. 
As we previously showed, in rat CG-2B glioma cells, 
the beta-adrenergic agonist (-)isoproterenol, causes a 
transient intracellular CAMP accumulation [4], ac- 
companied by an increase in c-j& mRNA content, 
which is also transient and peaks at 30 min [S]. This 
finding prompted us to investigate the possible role 
played by the early tnd ucible protein c-fos in the desen- 
sitization process. To address this question, we used 
2-aminopurine (2.AP). a purine analog which has been 
reported to selectively block c-fos gene expression [6]. 
2-AP has also been shown to selectively inhibit the in- 
duction of the interferon gene [7], interferon-inducible 
genes [S], human tumor necrosis fastor gene 191, and to 
enhance the expression of exogenous genes [lo]. 
Alhwhlirw* 2.AP. 2-aminopurinc; Bt:cAMP. N”.O”-dibutyryladc- 
nosinc 3’.5’-cyclic monophosphatc; IBMX. 3.isobutyl-l-methyl- 
xanthinc. 
Currespartdctrr~ uddrcw: G. Brookcr, Dept. of Biochemistry and Mo- 
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Previous studies from other laboratories have stated 
that prolonged treatment with 2-AP at the routinely 
used concentration of 10 mM did not significantly affect 
cellular metabolism [7,10]. We have previously shown 
that 2.AP. at 10 mM concentration, inhibited the in- 
crease in c-fos nuclear protein iminunorcactivity in- 
duced by isoproterenol in CG-2B cells [5]. We now 
report that SAP also partially prevents CAMP- 
mediated catecholamine desensitization in C6-2B cells. 
However, in contrast to what was stated in other reports 
[7,10], SAP causes a concentration-dependent inhibi- 
tion of total RNA, mRNA and protein synthesis, us 
measured by [‘Hluridine and [-lSS]methioninc incorpora- 
tion into cellular RNA and proteins. 
2. MATERIALS AND METHODS 
2.Aminopurinc(A-3509, lots l09F-7703 and 129F-0180). cyclohex- 
imidc. actinomycin-D. (-)isoprotcrenol HCI, Bt, CAMP and IBMX 
were purchased from Sigma Chemical Co. (St. Louis. MO). Forskolin 
was from Calbiochem (Bchring Dk~gnosiic. La Jolla, CA). [%]Mc- 
thioninc (>800 Ci/mmol) and vH]uridine (40 Ci/mrnol) wcrc obtuincd 
from Amersham Corp. (Arlington Heights. IL). Tissue culture 
products were from Gr;lnd island Biological Company (Grand Island, 
NY). 
Cells wcrc grown as monolayer cullures in Ham’s F-10 nuWicnt 
medium (CG-2B cells) or Dulbccco’s Modified Eagle Medium (HeLa, 
Swiss 3T3 and BALB/c cells? with 10% calf’serum. ?-AP stock solu- 
ti0r.s (150 mlc”.) :?‘crc ptcpxcd in phosphate-buffered saline [NaC) 137 
mM; KCI 2.7 mM; Nn2HPOd Y mM; Kl$PO, I.4 mM) containing 
glacial acetic acid (200:1, v/v), as described [7]. All expcrimcnts in- 
cluded control cells treated with the vehicle used to prepare 2-AP 
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solutions; the final pH of control and 2-AP solutions was adjusted IO 
7.0-7.2. Upon drug treatment a~ 37°C in serum fret-medium con- 
taining lhe phosphodicstcrvse inhibitor 15MX (0.1 mM), the intraccl- 
lular CAMP content was dctcrmincd as previously described 131, using 
IIK Allo-Flo automated radioimmunoassay system [I I]* (Atto Instru- 
ments. Inc.. Rockrillc. MD). Proteins wcrc measured by the Bradford 
assay [I21 using bovine serum albumin as standard. 
2.3. RNA rrrrd prokl~r s,~trrl~wh clawr~D~~triu~/ 
CG-23 and HcLa cells WI’C seeded on 34.well clusters ill the densit) 
of l-3 x IO’ cells/well and used while 80% confluent. unless othcrwisc 
indicated. Swiss 3T3 and BALB/c cells were plated tither at 2.5 x IO3 
cells/well, rcfcd at day 2. and used at day 7. when confluent and 
quicscem. or at 3.4 x lO~cclls/well, refed at day 2. und used 2days later 
while exponentially growing [ 131. Cells were labeled at 37°C for GO min 
with [‘Hluridinc (RNA synthesis) or 30 min with [“%i]merhioninc(pro- 
tein synthesis) at l-2 ~Cilmllwell. Precipitation with 10% ice-cold 
trichlocoacetic acid was followed by solubilization of the cells with I 
~~~l/wcll ol’ 0.2 M NaOW. 50 J&wII aliquots WCPC tested for protein 
convent by thr Uradford assay [I _9], RNA and protein synthesis wcrc 
mcasurcd by lbo incorporation of ~H]uridinc and [?S]mcthioninc. 
rcspoctivuly (dpm/mg protein per well) and cxpresscd as a percent of 
control, vehicle-treated cells, In many cxpcrimcnls. inhibition of RNA 
and protein synthesis by actinomycin-D (IO /rM) lrnd cyclohcximidc 
(30 1 M ). rcspcctively. was tested as an internal control and found to 
br: about 95%. Finally. for mRNA isolation. subconfluent CG-25 cells. 
grown in ISO-mm tissue culture plates. were exposed for 3 h to IO mM 
2.AP at 37°C. and given o 60 min [“Hjuridinc pulse (Z,Ki/ml). Control 
and d-AP trcalcd cells wcrc ~hcn harvested and poly(A)’ RNA ex- 
tracted by using the Fast Track mRNA isolation kit (tnritrogen 
Corpomlion. San Diego. CA) according to the manufacturer’s in- 
siructions. 
3. RESULTS 
As shown in Table 1. stimulated CAMP accumulation 
in C6-2B cells was not appreciably affected by the pres- 
ence of IO mM 2-AP when measured after a 30 min 
exposure to (-)isoproterenol (Iso). yet was 2-fold higher 
in 2-AP-treated cells after a 3-h Iso exposure. Also, a 
pretreatment with 2-.4P (IO mM) for 3 h did not signif- 
icantiy affect CAMP accumulation induced by a 30-min 
challenge with IOpM Iso (Fig. 1). However, after P 3-h 
lso treatment and a 30-min washing in the absence of 
2-AP. CB-2B cells showed desensitization such that only 
I I% of the original response to a subsequent re-chal- 
lenge with IO AM Iso was observed, as shown in F&l. 
When the cells were co-incubated for 3 h with 10 mM 
Table 1 
Erfec1 01 7.aminopurine on isoprotercnol-stimulillcd C6-25 ccl1 
CAMP conlent 
Time CAMP. pmol/mg prolcin 
Control 2.AP treated 
30 miii 6517 k 766 5937 t 288 
3h 650 ? 40 1351 + 65 
CG-2Bcells were incubated with isoproterenol (10pM) in the presence 
or abscncc of 2-AP (IO mM). Basal cell CAMP lcvcls were 70-25 
pmol/mg prolcin. The data arc presented as the mean ? SEM of 3 
separate experiments done in triplicate. 
2-AP and lso, a 2-4~fold greater CAMP response to a 
second challenge was observed (Fig. 1). However, if. 
following a 3-h co-incubation with 2-AP and Iso, 2-AP 
was omitted from the washing and rechallenge solu- 
tions, cell responsiveness was decreased by IO%, com- 
pared to cells which had been washed and rechallenged 
in the continuous presence of 2-AP, suggesting that the 
2-AP effect is reversible (data not shown). Furthermore, 
2-AP reduced the desensitization to Iso induced by a 3-h 
exposure to either the cell-permeable CAMP analogue 
Bt,cAMP (I mM) or forskolin (0.1 mM), a diterpene 
believed to directly activate the catalytic subunit of ade- 
nylate cyclase (Fig. I). 
Treatment with 2-AP severely impaired total RNA 
and protein synthesis in C6-2B and HeLa cells in a time- 
and concentration-dependenl lruanner. Time-course ex- 
periments of theeffect of IO mM 2-AP on the incorpora- 
tion of pH]uridine and [35S]methionine were carried out 
and the results from a representative experiment are 
shown in Fig. 2. In both cell lines, the maximal inhib- 
itory effect was reached afier a 3-h exposure to 2-AP, 
although at earlier time points 2-AP inhibited p’S]me- 
thionine incorporation more efficaciously in HeLa than 
in C6-2B cells. A similar time-dependency was observed 
for the inhibition of [“Hluridine incorporation by 10 
mM 2-AD. A treatment with 2-AP, at concentrations 
ranging from 0.01-50 mM for 3 h, increasingly inhibited 
both vH]uridine and [“5S]methionine incorporation in 
both C6-2B and HeLa cells, as shown in Fig. 3. Ex- 
posure of the cells to 50 mM 2-AP for 3 h. the timc- 
frame of our experiments, resulted in drastic changes in 
cell morphology and occasional cell detachment, where- 
as no apparent cytoloxicity was detected after a 3 h 
6000 
4 1 T 
13 CONTROL 
T 
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CONTROL ISOPROTERENOL &CAMP FORSLOUN 
PRETREATMENT (3 hr) 
Fig. I, 7-AP reduces isoprotcrcnol-. Bt:cAMP- and forskolin-induced 
refractoriness. C6-25 cells xvere incubated for 3 h with (solid bar) or 
without (open bars) IO mM I!-AP. in control serum-free medium, in 
medium containing IOyM (-)isoprotcrenol. I mM DtsAMP or 0.1 
mM forskolin. Cells were then washed S-times with strum-free 
medium (or 2-AP-containing serum-frm mLtiium for cells prcmzalcd 
with 2-AP) and CAMP was muasurcd ahcr a 30 min challenge with IO 
yM (-)isoprotcrenol in the prcscncc or in the abscncc of 7-AP. The 
data represent the mean 2 SEM of at leas1 3 separate cxperimcnts. 
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Fig. 7. Time-course of the inhibition of[“S]mclhioninc incorporation 
by 2-AP in C6-28 2nd WeLu cells. Cells were incubutcd in the presence 
or absence of IO mM 2.AP for the indicaled time points and u 30 min 
pulse with [“%]methionine was given (I5 min for the 0.15 h time poim). 
exposure to 10 mM 2-AP. The extent of inhibition of 
both [‘Hluridinc and [“Slmethionine incorporation was 
slightly greater in HeLa than in C6-2B cells, whereas no 
significant differences in 2-AP efficacy in inhibiting 
both [jH]uridinc and [%]methionine were observed bc- 
tween subconfluent and confluent C6-2B or HeLa cul- 
tures (Fig. 3B). The inhibitory effect of 2-AP was revcr- 8. P,.,O ce-2B 
M HoLa 
f 80- 
* 
0.01 0,l 
I*-AmirLpuri5nel. ‘IIM 
50 
Fig. 3. 2-AP conccxration-dcpcndcnt khibitior, of f’.k!]uridinc and 
[“Slmethioninc incorporation into C6-?D and I-IeLa cells. Cuhures 
wcrc cxposcd to increasing concentrations of?-AP for 3 b at 37OC and 
pulse lubclling was pcrformcd as dcscribcd in Materials und Methods. 
Values rcprcscnt the mean 2 SEM of 3 dctcrminaGons. 
sible since washing out 2-AP readily restored the ability 
of the cells to incorporate both [-tH]uridine and [35S]me- 
thionine (data not shown). Furthermore, in non-tumor 
cells, such as Swiss 3T3 and BALE/c mouse libroblasts, 
2-AP also inhibited RNA and protein synthesis in a 
concentration-dependent manner. However, both Swiss 
3T3 and BALBk cells exposed to LO mM 2-AP, showed 
mild changes in cell morphology, although to a much 
lesser degree than that observed in C6-2l3 and HeLa 
cells which had been exposed to 50 mM 2-AP. A IO-fold 
greater incorporation of [‘Hluridine and [%]me- 
thioninc (dpn+g protein) was detected in exponentially 
growing cultures compared to confluent, quiescent cul- 
tures. In both Swiss 3T3 and BALB/c lines, the extent 
of inhibition of [‘Hluridine incorporation by 2-AP was 
generally greater in exponentially growing cells com- 
pared to confluent cells. As shown in Fig. 4A, a 
rightward shift in the dose-response curve of the inhibi- 
tion of [3H]uridine incorporation by 2-AP was observed 
in confluent compared to exponentially growing Swiss 
60 1 A [‘HI-Uridine 
I I 
0.1 1 5 10 
[2-Aminopurinel, mM 
Fig. 4. Concentration-dependent inhibition of [“Hluridine and [‘%]rnc- 
thionine incorporation by 2-AP in Swiss 3T3 mouse tibroblasis. Ex- 
ponentially growing (0) and conHueni/quicscent cells (m) wcrc vcatcd 
;vith UP at :hc indicated cox~~l~a?i~n~, 2nd e GO min pulse wilh 
[“Hluridinc (A) or a 30 min pulse wirh ~?S]methionine (B) ai 2/Xilmll 
well was given. Total 7.AP treatment time was 3 h; proicin comeni 
was IO-2Opug (exponcntiully growing cultures) und IOO-17Opg (con- 
flueni cultures) per well. 
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Table II 
Eff’ect or Saminopurinc on [‘Hluridinc incorporation into C6-2B cell 
poly(A)‘RNA 
Control 3.AP-treated 
dpm/pg poly(A)’ RNA 40042 -t 528 10334 +I 1640 
Subconllucnt CB-2B cells wcrc incubated for 3 h with serum-free 
medium in the presence or abscncc (control) or SAP (IO mM). 
[‘H]Uridine pulse and RNA extraction were performed as described 
in Materials and Methods. 
3T3 cells. [%]methionine incorporation was usually in- 
hibited to a similar extent in actively growing and 
quiescent cultures, although high concentrations (5-10 
mM) of 2-AP caused a greater inhibition in confluent 
than in exponentially growing Swiss 3T3 cells (Fig. 4B). 
Similar results were obtained with BALB/c fbroblasts. 
Finally, 2-AP was found to inhibit mRNA synthesis. 
As shown in Table 11, the specific activity (dpnzlpg 
mRNA) of rH]uridine-labeled poly(A)+ RNA isolated 
from 2-AP-treated C6-2J3 cells was reduced 74% com- 
pared to control. poly(A)+ RNA yield was similar in 
control and 2-AP-treated cells; three 150~mm plates 
with equal cell density yielded 10.5 (control) and I I .2 
(2-AP) pg of poly(A)+ RNA, as determined from the 
absorption at 260 and 280 nm. 
4. DISCUSSION 
In this study, 2-AP, u blocker of c-fos gene expression 
[63. was used to investigate the possible role played by 
the early inducible proLein c-fos in the CAMP-mediated 
desensitization i C6-2B cells. 2-AP did not significantly 
affect acute CAMP accumulation elicited by a 30-min 
challenge with isoproterenol, but retarded the decline in 
cellular CAMP at longer time points. Furthermore, 2- 
AP partially prevented homologous as well as heter- 
ologous desensitization to catecholamincs in C6-26 
cells. However, a concentration-dependent inhibition of 
total RNA and protein synthesis was observed in C6-213 
cells treated with 2-AP for up io 3 h, the time-frame of 
our experiments, This unexpected result suggested to us 
that the reduction in desensitization caused by 2-AP, 
rather than being mediated by the selective inhibition of 
c-fus gene expression, could be accounted for by the 
genera1 inhibition of the RNA and protein synthesis, as 
we proposed earlier [l-3]. The lack of data, at least in 
the literature we were aware of, describing inhibitory 
effects of 2-AP on cell metabolism, led us to extend our 
studies to other cell lines. We chose human carcinoma 
HeLa cells because this cell line had been used in studies 
where other investigators had stated that 2-AP was not 
associated with inhibition of RNA and protein synthesis 
[7, i 0;. Indeed. 2-AP inhibited RNA and protein syn- 
thesis in HeLa cells with a time-course and a concentra- 
tion-dependency similar to those observed in C6-2B 
cells. As 2-AP is a purine analog, one could expect it to 
be a more potent inhibitor in rapidly dividing than in 
stationary, resting cultures. No significant differences in 
2-AP efficacy were observed between &confluent and 
confluent C6-25 and HeLa cultures. However, in C6-2B 
and HeLa cells, cell confluency does not temporally 
coincide with arrested growth and quiescence because, 
due to their tumoral nature, these cell lines are not 
contact-inhibited. Therefore, to appropriately address 
the question of whether 2-AP inhibits RNA and protein 
synthesis more strongly in actively growing rather than 
quiescenl cultures. we extended our studies to Swiss 3T3 
and BALB/c mouse libroblasts. In these cell lines, 2-AP 
inhibited the incorporation of labelled uridine more 
efficaciously in exponentially growing than in confluent 
cultures, whereas the incorporation of labelled me- 
thionine was similar in both growth states. Interest- 
ingly, 2-AP appears to be more cytotoxic in non-tu- 
moral than in tumoral cells, although the maximal in- 
hibition of RNA and protein synlhesis was generally 
greater in C6-26 and HeLa than in Swiss 3T3 and 
BALB/c cell lines. To investigate whether these differen- 
tial effects on tumor vs. non-tumor systems are due to 
the purine analog properties of 2-AP or to unique mode 
of action of the drug itself, although interesting, is 
beyond the scope of this paper. 
Finally, we showed that messenger RNA synthesis is 
also markedly inhibited in 2-AP-treated C6-2B cells. 
Thus, since 2-AP inhibits mRNA synthesis, its action 
might be expected to be more demonstrable on short 
half-life proteins or on genes undergoing active 
transcription, such as the early inducible gene c-fos or 
the putatively induced gene(s) which we suggested are 
involved in some aspect of the CAMP-mediated esen- 
sitization of hormonal responses. However, since 2-AP 
blocks general RNA and protein synthesis. aconclusion 
about the role of c-fos in the refractoriness process 
cannot be drawn from our present results and different 
studies are needed to properly address this question. 
Nevertheless, it is clear that the inhibitory activity on 
RNA and protein synthesis must be taken mto account 
when 2-AP is used to pinpoint a role for c-fos in any 
cellular process. Finally , 2-AP is also a protein kinasc 
inhibitor whose only two in vitro substrates known to 
date are the heme-regulated kinasc and the double- 
stranded RNA-dependent eukaryotic iniliation factor 
(elF)-Za kinase [14-163. Although there is no evidence 
that 2-AP might be a general inhibitor of cellular 
kinases, the possibility that 2-AP acts through an as yet 
unknown phosphorylating protein. whose activity 
might be required for continuous responsiveness to hor- 
monal stimulation or RNA and protein synthesis. 
cannot be ruled out. 
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